Patrick M. Sweeney & Associates’s AbbVie ABBV Stock Holding History

Patrick M. Sweeney & Associates’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$5.77M	Buy	26,535 +25	+0.1%	+$5.55K	3.7%	6
2025 Q4	$6.06M	Sell	26,510 -5	-0%	-$1.14K	3.79%	5
2025 Q3	$6.14M	Buy	26,515 +30	+0.1%	+$6.11K	3.97%	5
2025 Q2	$5.01M	Buy	26,485 +1	+0%	+$186	3.45%	6
2025 Q1	$5.55M	Buy	26,484 +1	+0%	+$194	4.15%	4
2024 Q4	$4.71M	Buy	26,483 +2	+0%	+$368	3.53%	6
2024 Q3	$5.23M	Buy	26,481 +1	+0%	+$187	3.84%	4
2024 Q2	$4.54M	Buy	26,480 +101	+0.4%	+$16.7K	3.67%	7
2024 Q1	$4.8M	Buy	26,379 +2	+0%	+$345	3.95%	7
2023 Q4	$4.09M	Buy	+26,377	New	+$3.85M	3.74%	6

Other funds holding ABBV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Patrick M. Sweeney & Associates's ABBV Position: Q1 2026 in Review

Patrick M. Sweeney & Associates increased its AbbVie (ABBV) stake by 0.09% in Q1 2026, buying an estimated $5.55K and bringing the position to 26,535 shares worth $5.77M. The position accounts for 3.7% of the portfolio, ranked #6.

Patrick M. Sweeney & Associates first reported a position in ABBV in Q4 2023 and has held it in 10 quarters since. The position peaked at $6.14M in Q3 2025. 4,077 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

Patrick M. Sweeney & Associates held 26,535 shares of AbbVie worth $5.77M as of Q1 2026.
Patrick M. Sweeney & Associates bought 25 AbbVie shares in Q1 2026, an estimated $5.55K.
AbbVie made up 3.7% of Patrick M. Sweeney & Associates's portfolio in Q1 2026, its #6 holding.
Patrick M. Sweeney & Associates first reported a position in AbbVie in Q4 2023 and has held it in 10 quarters since.
Patrick M. Sweeney & Associates's AbbVie position peaked at $6.14M in Q3 2025.
4,077 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Patrick M. Sweeney & Associates's 13F filing for Q1 2026, filed 7 May 2026.